Van Hulzen Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $357K | Buy |
3,453
+4
| +0.1% | +$357 | 0.03% | 291 |
|
|
2026
Q1 | $248K | Sell |
3,449
-626
| -15% | -$48.2K | 0.02% | 320 |
|
|
2025
Q4 | $323K | Sell |
4,075
-34
| -0.8% | -$2.68K | 0.02% | 264 |
|
|
2025
Q3 | $310K | Sell |
4,109
-195
| -5% | -$13.4K | 0.02% | 262 |
|
|
2025
Q2 | $297K | Sell |
4,304
-195
| -4% | -$12.8K | 0.02% | 257 |
|
|
2025
Q1 | $305K | Sell |
4,499
-143
| -3% | -$8.56K | 0.03% | 254 |
|
|
2024
Q4 | $208K | Sell |
4,642
-1,094
| -19% | -$61.4K | 0.02% | 306 |
|
|
2024
Q3 | $361K | Sell |
5,736
-495
| -8% | -$28.9K | 0.03% | 244 |
|
|
2024
Q2 | $368K | Buy |
6,231
+606
| +11% | +$37.9K | 0.02% | 227 |
|
|
2024
Q1 | $449K | Buy |
5,625
+5
| +0.1% | +$382 | 0.03% | 230 |
|
|
2023
Q4 | $444K | Sell |
5,620
-70
| -1% | -$4.98K | 0.03% | 231 |
|
|
2023
Q3 | $397K | Sell |
5,690
-600
| -10% | -$42.5K | 0.03% | 227 |
|
|
2023
Q2 | $435K | Sell |
6,290
-2,300
| -27% | -$164K | 0.04% | 200 |
|
|
2023
Q1 | $638K | Buy |
8,590
+266
| +3% | +$22.3K | 0.06% | 154 |
|
|
2022
Q4 | $776K | Buy |
8,324
+36
| +0.4% | +$3.47K | 0.09% | 140 |
|
|
2022
Q3 | $790K | Sell |
8,288
-243
| -3% | -$24.1K | 0.1% | 134 |
|
|
2022
Q2 | $790K | Buy |
8,531
+43
| +0.5% | +$4.2K | 0.09% | 130 |
|
|
2022
Q1 | $859K | Buy |
8,488
+400
| +5% | +$42K | 0.09% | 124 |
|
|
2021
Q4 | $834K | Buy |
8,088
+1,300
| +19% | +$120K | 0.09% | 130 |
|
|
2021
Q3 | $576K | Hold |
6,788
| – | – | 0.09% | 136 |
|
|
2021
Q2 | $566K | Sell |
6,788
-550
| -7% | -$45K | 0.08% | 131 |
|
|
2021
Q1 | $552K | Hold |
7,338
| – | – | 0.09% | 126 |
|
|
2020
Q4 | $501K | Sell |
7,338
-1,600
| -18% | -$104K | 0.08% | 140 |
|
|
2020
Q3 | $522K | Hold |
8,938
| – | – | 0.08% | 122 |
|
|
2020
Q2 | $581K | Sell |
8,938
-2,421
| -21% | -$152K | 0.09% | 115 |
|
|
2020
Q1 | $674K | Sell |
11,359
-1,875
| -14% | -$125K | 0.15% | 95 |
|
|
2019
Q4 | $983K | Sell |
13,234
-148,602
| -92% | -$10.4M | 0.19% | 89 |
|
|
2019
Q3 | $10.2M | Buy |
161,836
+2,972
| +2% | +$176K | 2.16% | 8 |
|
|
2019
Q2 | $8.66M | Buy |
158,864
+14,235
| +10% | +$767K | 1.89% | 12 |
|
|
2019
Q1 | $7.8M | Buy |
144,629
+130,295
| +909% | +$8.04M | 2.1% | 9 |
|
|
2018
Q4 | $939K | Buy |
14,334
+11,622
| +429% | +$868K | 0.27% | 70 |
|
|
2018
Q3 | $213K | Buy |
+2,712
| New | +$194K | 0.06% | 210 |
|
|
2018
Q1 | – | Sell |
-6,900
| Closed | -$500K | – | 211 |
|
|
2017
Q4 | $500K | Buy |
+6,900
| New | +$502K | 0.15% | 116 |
|
|
2017
Q1 | – | Sell |
-6,560
| Closed | -$518K | – | 130 |
|
|
2016
Q4 | $518K | Sell |
6,560
-90
| -1% | -$7.28K | 0.24% | 80 |
|
|
2016
Q3 | $592K | Buy |
+6,650
| New | +$628K | 0.32% | 70 |
|
Other funds holding CVS
Van Hulzen Asset Management's CVS Position: Q2 2026 in Review
Van Hulzen Asset Management increased its CVS Health (CVS) stake by 0.12% in Q2 2026, buying an estimated $357 and bringing the position to 3,453 shares worth $357K. The position accounts for 0.03% of the portfolio, ranked #291.
Van Hulzen Asset Management first reported a position in CVS in Q3 2016 and has held it in 35 quarters since. The position peaked at $10.2M in Q3 2019. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Van Hulzen Asset Management held 3,453 shares of CVS Health worth $357K as of Q2 2026.
- Van Hulzen Asset Management bought 4 CVS Health shares in Q2 2026, an estimated $357.
- CVS Health made up 0.03% of Van Hulzen Asset Management's portfolio in Q2 2026, its #291 holding.
- Van Hulzen Asset Management first reported a position in CVS Health in Q3 2016 and has held it in 35 quarters since.
- Van Hulzen Asset Management's CVS Health position peaked at $10.2M in Q3 2019.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Van Hulzen Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.